Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amneal Ready To Go Head-To-Head With Mylan’s Xulane In US
Gains 180 Days Of CGT Exclusivity For Generic Of Ortho Evra Contraceptive Patch
Mar 01 2021
•
By
David Wallace
Amneal will benefit from 180 days of CGT exclusivity • Source: Shutterstock
More from Products
More from Generics Bulletin
